Sign up to save your podcasts
Or
Share Expert Perspectives & Best Practice Recommendations for Therapeutic Sequencing in NSCLC Without a Driver Mutation
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Expert Perspectives & Best Practice Recommendations for Therapeutic Sequencing in NSCLC Without a Driver Mutation
CME credits: 0.25
Valid until: 23-05-2020
Claim your CME credit at https://reachmd.com/programs/cme/expert-perspectives-and-best-practice-recommendations-for-therapeutic-sequencing-in-nsclc/10737/
In this 15-minute accredited CME audiocast, Dr. Tsao presents 2 cases of patients with advanced NSCLC without a driver mutation and discusses how to manage these patients after first-line treatment. The first case is a patient who progresses on platinum-based chemotherapy, and the second case is a patient who progresses on pembrolizumab-pemetrexed-carboplatin.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 23-05-2020
Claim your CME credit at https://reachmd.com/programs/cme/expert-perspectives-and-best-practice-recommendations-for-therapeutic-sequencing-in-nsclc/10737/
In this 15-minute accredited CME audiocast, Dr. Tsao presents 2 cases of patients with advanced NSCLC without a driver mutation and discusses how to manage these patients after first-line treatment. The first case is a patient who progresses on platinum-based chemotherapy, and the second case is a patient who progresses on pembrolizumab-pemetrexed-carboplatin.